Corvus Pharmaceuticals(CRVS) - 2025 Q4 - Earnings Call Transcript

Corvus Pharmaceuticals (NasdaqGM:CRVS) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsLeiv Lea - CFOLi Watsek - DirectorRichard Miller - CEOSean Lee - VP of Equity ResearchZack Kubow - Senior Group Director of Investor RelationsConference Call ParticipantsAydin Huseynov - Equity Research AnalystGraig Suvannavejh - Senior AnalystJeff Jones - Managing Director and Senior AnalystRoger Song - Senior Equity Research AnalystOperatorGood afternoon, everyone, and thank you for standing by and ...